Reuters -- China Nuokang Bio-Pharmaceutical Inc priced shares in its initial public offering at a lower-than-expected $9 each on Wednesday, raising about $45 million, the issue’s underwriter said.
Reuters -- China Nuokang Bio-Pharmaceutical Inc priced shares in its initial public offering at a lower-than-expected $9 each on Wednesday, raising about $45 million, the issue’s underwriter said.
